[1]
Uddin Md S, Kabir Md T, Rahman Md H, et al. Exploring the Multifunctional Neuroprotective Promise of Rasagiline Derivatives for Multi-Dysfunctional Alzheimer’s Disease. Curr Pharm Des 2020; 26(37): 4690-8.
[2]
Mueed Z, Mehta D, Rai PK, Kamal MA, Poddar NK. Cross-Interplay between Osmolytes and mTOR in Alzheimer’s Disease Pathogenesis. Curr Pharm Des 2020; 26(37): 4699-711.
[3]
Arslan J, Gilani AU, Jamshed H, Khan SF, Kamal MA. Edible Nuts for Memory. Curr Pharm Des 2020; 26(37): 4712-20.
[4]
Kumar B, Pandey M, Pottoo FH, Fayaz F, Sharma A, Sahoo PK. Liposomes: Novel Drug Delivery Approach for Targeting Parkinson’s Disease. Curr Pharm Des 2020; 26(37): 4721-37.
[5]
Ghanta MK, Elango P, Bhaskar LVKS. Current Therapeutic Strategies and Perspectives for Neuroprotection in Parkinson’s Disease. Curr Pharm Des 2020; 26(37): 4738-46.
[6]
Asif M, Usman M, Ayub S, et al. Role of ATP-Binding Cassette Transporter Proteins in CNS Tumors: Resistance-Based Perspectives and Clinical Updates. Curr Pharm Des 2020; 26(37): 4747-63.
[7]
Liu S, Wang L, Jiang D, et al. Sumoylation as an Emerging Target in Therapeutics against Cancer. Curr Pharm Des 2020; 26(37): 4764-76.
[8]
Mollazadeh H, Mohtashami E, Mousavi SH, et al. Deciphering the Role of Glutamate Signaling In Glioblastoma Multiforme: Current Therapeutic Modalities and Future Directions. Curr Pharm Des 2020; 26(37): 4777-88.
[9]
Chen P, Li Z, Li Y, Ahmad SS, Kamal MA, Huo X. The Language Development Via FOXP2 in Autism Spectrum Disorder: A Review. Curr Pharm Des 2020; 26(37): 4789-95.